Brandon Folkes

H.C. Wainwright & Co.

Recent Articles about Cardiol Therapeutics

Biotech Announces Topline Results From Cardiovascular Drug Trial 08/11/2025

Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) Analyst Brandon Folkes reviews Cardiol Therapeutics Inc. after it announced the topline results from its Phase II ARCHER trial of CardiolRx in acute myocarditis.

Canadian Pharmaceutical Company Discovers Breakthrough Cardiovascular Treatment 08/11/2025

Clinical-stage life sciences company Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) announces topline results from its Phase II clinical study involving patients with acute myocarditis. Read why analysts like this pharmaceutical stock.